# Measuring Active Microglia in Progressive Multiple Sclerosis

> **NCT02207075** · — · COMPLETED · sponsor: **Weill Medical College of Cornell University** · enrollment: 50 (actual)

## Conditions studied

- Secondary Progressive Multiple Sclerosis

## Interventions

- **DRUG:** [C11]PK-1195 PET scan

## Key facts

- **NCT ID:** NCT02207075
- **Lead sponsor:** Weill Medical College of Cornell University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2014-07
- **Primary completion:** 2020-12
- **Final completion:** 2020-12
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2022-01-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02207075

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02207075, "Measuring Active Microglia in Progressive Multiple Sclerosis". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02207075. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*